A citation-based method for searching scientific literature

Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, René DePont Christensen, Whitney Graybill, Mansoor R Mirza, Colleen McCormick, Domenica Lorusso, Paul Hoskins, Gilles Freyer, Klaus Baumann, Kris Jardon, Andrés Redondo, Richard G Moore, Christof Vulsteke, Roisin E O'Cearbhaill, Bente Lund, Floor Backes, Pilar Barretina-Ginesta, Ashley F Haggerty, Maria J Rubio-Pérez, Mark S Shahin, Giorgia Mangili, William H Bradley, Ilan Bruchim, Kaiming Sun, Izabela A Malinowska, Yong Li, Divya Gupta, Bradley J Monk. N Engl J Med 2019
Times Cited: 338



Timothy J Perren, Ann Marie Swart, Jacobus Pfisterer, Jonathan A Ledermann, Eric Pujade-Lauraine, Gunnar Kristensen, Mark S Carey, Philip Beale, Andrés Cervantes, Christian Kurzeder, Andreas du Bois, Jalid Sehouli, Rainer Kimmig, Anne Stähle, Fiona Collinson, Sharadah Essapen, Charlie Gourley, Alain Lortholary, Frédéric Selle, Mansoor R Mirza, Arto Leminen, Marie Plante, Dan Stark, Wendi Qian, Mahesh K B Parmar, Amit M Oza. N Engl J Med 2011
Times Cited: 1169




List of shared articles



Times cited


Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM).
Angiolo Gadducci, Giovanni D Aletti, Fabio Landoni, Roberta Lazzari, Giorgia Mangili, Paola Olivas, Sandro Pignata, Vanda Salutari, Enrico Sartori, Giovanni Scambia,[...]. Tumori 2021
1

Asian perspective on debulking surgery for advanced ovarian cancer: An E-survey.
Soo Jin Park, Eun Ji Lee, Taek Sang Lee, Kung-Liahng Wang, Aikou Okamoto, Kazunori Ochiai, Hee Seung Kim, Jae-Weon Kim. Eur J Surg Oncol 2021
1

Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial.
Céline Callens, Dominique Vaur, Isabelle Soubeyran, Etienne Rouleau, Pierre-Alexandre Just, Erell Guillerm, Lisa Golmard, Nicolas Goardon, Nicolas Sevenet, Odile Cabaret,[...]. J Natl Cancer Inst 2021
2

PARP inhibitors in ovarian cancer: An overview of the practice-changing trials.
Tiffany Foo, Angela George, Susana Banerjee. Genes Chromosomes Cancer 2021
6

Systemic treatment of newly diagnosed advanced epithelial ovarian cancer: From chemotherapy to precision medicine.
J Alejandro Perez-Fidalgo, Francisco Grau, Lorena Fariñas, Ana Oaknin. Crit Rev Oncol Hematol 2021
3

SEOM clinical guideline in ovarian cancer (2020).
A Redondo, E Guerra, L Manso, C Martin-Lorente, J Martinez-Garcia, J A Perez-Fidalgo, M Q Varela, M J Rubio, M P Barretina-Ginesta, A Gonzalez-Martin. Clin Transl Oncol 2021
1

Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial.
Sandro Pignata, Domenica Lorusso, Florence Joly, Ciro Gallo, Nicoletta Colombo, Cristiana Sessa, Aristotelis Bamias, Vanda Salutari, Frédèric Selle, Simona Frezzini,[...]. Lancet Oncol 2021
7

Poly(ADP-ribose) polymerase inhibitors in combination with anti-angiogenic agents for the treatment of advanced ovarian cancer.
Olivia Le Saux, Hélène Vanacker, Fatma Guermazi, Mélodie Carbonnaux, Clémence Roméo, Louis Larrouquère, Olivier Trédan, Isabelle Ray-Coquard. Future Oncol 2021
0



Report from the European Society of Gynaecological Oncology (ESGO) 2020 State-of-the-Art Virtual Meeting.
Zoia Razumova, Nicolò Bizzarri, Joanna Kacperczyk-Bartnik, Andrei Pletnev, Antonio Gonzalez Martin, Jan Persson. Int J Gynecol Cancer 2021
0

Update on the secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a narrative review.
Carmine Conte, Anna Fagotti, Giacomo Avesani, Charlotte Trombadori, Alex Federico, Marco D'Indinosante, Maria Teresa Giudice, Silvia Pelligra, Claudio Lodoli, Claudia Marchetti,[...]. Ann Transl Med 2021
0

PARP Inhibitor in Platinum-Resistant Ovarian Cancer: Single-Center Real-World Experience.
Amit Agarwal, Saphalta Baghmar, Chandragouda Dodagoudar, Suhail Qureshi, Aseem Khurana, Vikas Vaibhav, Guresh Kumar. JCO Glob Oncol 2021
0



Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39).
Kathleen N Moore, Michael Bookman, Jalid Sehouli, Austin Miller, Charles Anderson, Giovanni Scambia, Tashanna Myers, Cagatay Taskiran, Katina Robison, Johanna Mäenpää,[...]. J Clin Oncol 2021
4